TfR.mAb-siMSTN

N/A

Report date: 2024/04/11 14:02:17

Base Information

Drug NameTfR.mAb-siMSTN

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate > Antibody-siRNA conjugate

Mechanisms of ActionRNA interferenceAnti-Transferrin receptor protein 1Growth/differentiation factor 8 inhibitors

TargetsTransferrin receptor protein 1Growth/differentiation factor 8

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAvidity Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesAvidity Biosciences Inc

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophy, Duchenne

Inactive IndicationsN/A

Other Information

ATC CodeN/A